Nitto Denko Of Japan Buys U.S. CMO Avecia Biotechnology
This article was originally published in PharmAsia News
Executive Summary
Japan's Nitto Denko said it has bought U.S.-based Avecia Biotechnology, a contract manufacturing organization specializing in nucleic acid drugs